Evommune (EVMN) Other Working Capital Changes (2024 - 2026)

Evommune (EVMN) has 3 years of Other Working Capital Changes data on file, last reported at $85000.0 in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $85000.0, up 102.83% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.8 million (changed N/A YoY), and the FY2025 annual result was $2.4 million, up 133.04% from the prior year.
• Other Working Capital Changes fell to $85000.0 in Q1 2026 per EVMN's latest filing, from $372000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $706000.0 in Q4 2024 and troughed at -$3.0 million in Q1 2025.
• A 3-year average of -$459250.0 and a median of $228500.0 in 2025 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes tumbled 47.31% in 2025, then surged 102.83% in 2026.
• A 3-year view of Other Working Capital Changes shows it stood at $706000.0 in 2024, then plunged by 47.31% to $372000.0 in 2025, then tumbled by 77.15% to $85000.0 in 2026.
• Business Quant data shows EVMN's Other Working Capital Changes at $85000.0 in Q1 2026, $372000.0 in Q4 2025, and -$3.0 million in Q1 2025.